Edgewell Personal Care Company (EPC)
USD 29.67
(-2.43%)
USD 29.67
(-2.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 285.4 Million USD | -10.14% |
| 2023 | 317.6 Million USD | 10.75% |
| 2022 | 285.4 Million USD | -13.88% |
| 2021 | 301 Million USD | 22.5% |
| 2020 | 237.3 Million USD | -25.75% |
| 2019 | -235.79 Million USD | 0.03% |
| 2018 | 382.4 Million USD | -16.74% |
| 2017 | 112.4 Million USD | 7.31% |
| 2016 | 388.2 Million USD | 130.23% |
| 2015 | -296.1 Million USD | -73.01% |
| 2014 | 688.7 Million USD | -17.79% |
| 2013 | 842.6 Million USD | 23.05% |
| 2012 | 853.2 Million USD | 3.58% |
| 2011 | 707.7 Million USD | -5.45% |
| 2010 | 808 Million USD | -6.23% |
| 2009 | 720.4 Million USD | -9.28% |
| 2008 | 817.2 Million USD | 33.66% |
| 2007 | 625.9 Million USD | 10.24% |
| 2006 | 553.3 Million USD | -1.28% |
| 2005 | 561.8 Million USD | 11.12% |
| 2004 | 496.4 Million USD | 38.98% |
| 2003 | 356.4 Million USD | -2.34% |
| 2002 | 364.7 Million USD | -7.96% |
| 2001 | 274.6 Million USD | -4.53% |
| 2000 | 406.3 Million USD | 20.87% |
| 1999 | 350.7 Million USD | 9.53% |
| 1998 | 320.2 Million USD | 1.11% |
| 1997 | 316.7 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 108.3 Million USD | 11.47% |
| 2024 Q1 | 55.1 Million USD | -35.25% |
| 2024 Q2 | 93 Million USD | 109.32% |
| 2023 Q1 | 61.5 Million USD | -9.02% |
| 2023 Q2 | 72.8 Million USD | 18.37% |
| 2023 Q4 | 82.6 Million USD | -28.11% |
| 2023 Q3 | 114.9 Million USD | 57.83% |
| 2023 FY | - USD | 10.75% |
| 2022 Q4 | 67.6 Million USD | -15.82% |
| 2022 FY | - USD | -13.88% |
| 2022 Q1 | 57.1 Million USD | -22.21% |
| 2022 Q2 | 71.8 Million USD | 25.74% |
| 2022 Q3 | 80.3 Million USD | 11.84% |
| 2021 Q2 | 87.8 Million USD | 28.18% |
| 2021 Q4 | 73.4 Million USD | -24.33% |
| 2021 FY | - USD | 22.5% |
| 2021 Q1 | 68.5 Million USD | 49.89% |
| 2021 Q3 | 97 Million USD | 10.48% |
| 2020 Q1 | 67.3 Million USD | 4.5% |
| 2020 FY | - USD | -25.75% |
| 2020 Q2 | 71.7 Million USD | 6.54% |
| 2020 Q3 | 76 Million USD | 6.0% |
| 2020 Q4 | 45.7 Million USD | -39.87% |
| 2019 Q3 | 112.8 Million USD | -4.33% |
| 2019 Q1 | 62.8 Million USD | -1.57% |
| 2019 FY | - USD | 0.03% |
| 2019 Q4 | 64.4 Million USD | -42.91% |
| 2019 Q2 | 117.9 Million USD | 87.74% |
| 2018 Q1 | 59.8 Million USD | -31.89% |
| 2018 Q2 | 132.1 Million USD | 120.9% |
| 2018 Q3 | 102.5 Million USD | -22.41% |
| 2018 FY | - USD | -16.74% |
| 2018 Q4 | 63.8 Million USD | -37.76% |
| 2017 Q1 | 92.6 Million USD | -22.45% |
| 2017 FY | - USD | 7.31% |
| 2017 Q4 | 87.8 Million USD | -26.22% |
| 2017 Q3 | 119 Million USD | -12.37% |
| 2017 Q2 | 135.8 Million USD | 46.65% |
| 2016 Q2 | 138.7 Million USD | 59.24% |
| 2016 Q1 | 87.1 Million USD | 180.06% |
| 2016 Q3 | 82.8 Million USD | -40.3% |
| 2016 Q4 | 119.4 Million USD | 44.2% |
| 2016 FY | - USD | 130.23% |
| 2015 Q4 | 31.1 Million USD | -31.35% |
| 2015 FY | - USD | -73.01% |
| 2015 Q1 | 167.2 Million USD | 15.87% |
| 2015 Q2 | 184 Million USD | 10.05% |
| 2015 Q3 | 45.3 Million USD | -75.38% |
| 2014 Q3 | 180.1 Million USD | -5.11% |
| 2014 Q4 | 144.3 Million USD | -19.88% |
| 2014 FY | - USD | -17.79% |
| 2014 Q1 | 207.4 Million USD | -6.37% |
| 2014 Q2 | 189.8 Million USD | -8.49% |
| 2013 Q4 | 221.5 Million USD | 12.49% |
| 2013 FY | - USD | 23.05% |
| 2013 Q3 | 196.9 Million USD | 7.48% |
| 2013 Q2 | 183.2 Million USD | -21.64% |
| 2013 Q1 | 233.8 Million USD | 28.32% |
| 2012 Q3 | 124.6 Million USD | -14.42% |
| 2012 Q4 | 182.2 Million USD | 46.23% |
| 2012 Q1 | 228.4 Million USD | 43.65% |
| 2012 FY | - USD | 3.58% |
| 2012 Q2 | 145.6 Million USD | -36.25% |
| 2011 Q4 | 159 Million USD | -8.52% |
| 2011 Q1 | 194.9 Million USD | 83.35% |
| 2011 Q2 | 127.7 Million USD | -34.48% |
| 2011 Q3 | 173.8 Million USD | 36.1% |
| 2011 FY | - USD | -5.45% |
| 2010 FY | - USD | -6.23% |
| 2010 Q1 | 194.9 Million USD | 105.59% |
| 2010 Q4 | 106.3 Million USD | -35.06% |
| 2010 Q3 | 163.7 Million USD | 0.99% |
| 2010 Q2 | 162.1 Million USD | -16.83% |
| 2009 Q1 | 243.4 Million USD | 31.92% |
| 2009 FY | - USD | -9.28% |
| 2009 Q4 | 94.8 Million USD | -31.95% |
| 2009 Q3 | 139.3 Million USD | -9.78% |
| 2009 Q2 | 154.4 Million USD | -36.57% |
| 2008 Q1 | 195.8 Million USD | 100.2% |
| 2008 Q4 | 184.5 Million USD | 27.24% |
| 2008 Q2 | 150.6 Million USD | -23.08% |
| 2008 FY | - USD | 33.66% |
| 2008 Q3 | 145 Million USD | -3.72% |
| 2007 FY | - USD | 10.24% |
| 2007 Q3 | 89 Million USD | -21.38% |
| 2007 Q2 | 113.2 Million USD | -42.36% |
| 2007 Q1 | 196.4 Million USD | 180.17% |
| 2007 Q4 | 97.8 Million USD | 9.89% |
| 2006 Q4 | 70.1 Million USD | -16.45% |
| 2006 Q1 | 194.2 Million USD | 104.21% |
| 2006 Q3 | 83.9 Million USD | -5.62% |
| 2006 Q2 | 88.9 Million USD | -54.22% |
| 2006 FY | - USD | -1.28% |
| 2005 FY | - USD | 11.12% |
| 2005 Q2 | 86.6 Million USD | -52.91% |
| 2005 Q3 | 79.9 Million USD | -7.74% |
| 2005 Q4 | 95.1 Million USD | 19.02% |
| 2005 Q1 | 183.9 Million USD | 123.18% |
| 2004 Q4 | 82.4 Million USD | 10.01% |
| 2004 Q3 | 74.9 Million USD | 18.14% |
| 2004 Q2 | 63.4 Million USD | -62.51% |
| 2004 FY | - USD | 38.98% |
| 2004 Q1 | 169.1 Million USD | 95.72% |
| 2003 FY | - USD | -2.34% |
| 2003 Q3 | 20.9 Million USD | -62.45% |
| 2003 Q2 | 49 Million USD | -61.36% |
| 2003 Q1 | 126.8 Million USD | 51.67% |
| 2003 Q4 | 69.4 Million USD | 369.57% |
| 2002 Q4 | 82.5 Million USD | 36.6% |
| 2002 Q3 | 61.2 Million USD | 47.47% |
| 2002 Q2 | 36.8 Million USD | -67.78% |
| 2002 FY | - USD | -7.96% |
| 2002 Q1 | 126.1 Million USD | -36.4% |
| 2001 Q1 | 103.7 Million USD | 47.81% |
| 2001 Q4 | 53.5 Million USD | 12011.76% |
| 2001 Q3 | -1.7 Million USD | -108.81% |
| 2001 FY | - USD | -4.53% |
| 2001 Q2 | 18.8 Million USD | -81.58% |
| 2000 Q4 | 70.9 Million USD | 32.52% |
| 2000 Q2 | -1.2 Million USD | -100.69% |
| 2000 Q1 | 173.7 Million USD | 120.71% |
| 2000 FY | - USD | 20.87% |
| 2000 Q3 | 53.5 Million USD | 4558.33% |
| 1999 Q1 | 94.6 Million USD | 0.0% |
| 1999 Q3 | 34.7 Million USD | 187.63% |
| 1999 Q2 | -39.6 Million USD | -141.86% |
| 1999 FY | - USD | 9.53% |
| 1999 Q4 | 78.7 Million USD | 126.8% |
| 1998 FY | - USD | 1.11% |
| 1997 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Church & Dwight Co., Inc. | 1.25 Billion USD | 77.319% |
| Colgate-Palmolive Company | 4.5 Billion USD | 93.67% |
| The Clorox Company | 736 Million USD | 61.223% |
| Coty Inc. | 1 Billion USD | 71.577% |
| The Estée Lauder Companies Inc. | 2.4 Billion USD | 88.128% |
| e.l.f. Beauty, Inc. | 188.31 Million USD | -51.556% |
| Grove Collaborative Holdings, Inc. | -21.29 Million USD | 1440.347% |
| Hims & Hers Health, Inc. | -19.93 Million USD | 1531.437% |
| Kimberly-Clark Corporation | 3.06 Billion USD | 90.694% |
| Kenvue Inc. | 3.17 Billion USD | 91.011% |
| Nu Skin Enterprises, Inc. | 137.65 Million USD | -107.325% |
| The Procter & Gamble Company | 23.84 Billion USD | 98.803% |
| Spectrum Brands Holdings, Inc. | 323.9 Million USD | 11.886% |